Displaying items by tag: department of pathology

Suits for Success’ impact transcends to three other UAB closets and a community closet serving students, patients and underprivileged women facing domestic violence.
UAB is joining the Red Cross in encouraging the public to donate blood now.
Description of this mechanism offers a promising therapeutic target to limit lung injury and death. Lower respiratory tract infections, including bacterial pneumonia, are the fourth-leading cause of death worldwide, with 120 million to 156 million cases and 1.4 million deaths a year.
President Ray L. Watts, M.D., and Anupam Agarwal, M.D., dean of the Heersink School of Medicine, invite you to the Distinguished Faculty Lecture honoring Casey Weaver, M.D., recipient of the 2022-2023 Distinguished Faculty Lecturer Award.
Mechanistic findings in this study may pave the way for future time-restricted feeding studies in muscle, providing a natural and affordable form of alternative therapy for managing pathologies related to metabolism and obesity.
The researcher says this proposal will analyze the novel concept that circadian disruption presents an additional challenge to mitochondrial function and liver health in the alcohol consumer.
Insights that are not possible with conventional two-dimensional platforms include characterization of obliterated airways in tuberculosis and hemorrhage from ruptured blood vessels in COVID-19 lungs, at near-microscopic levels.
Experiments reveal that a catalytic subunit of CK2, called CK2α, is an important regulator of mouse CD8+ T cell activation, metabolic reprogramming and differentiation, both in vitro and in a mouse-infection model by the intracellular pathogen Listeria monocytogenes.
The funding will be used to purchase cutting-edge equipment to assist with high-containment research productivity and pandemic preparedness at UAB.
The funding from the Norma Livingston Ovarian Cancer Foundation will help further ovarian cancer research to advance therapeutic treatments.
UAB patients who meet the criteria to be tested can talk to their physician about obtaining a test.
The researchers found that ARID1A-deficient bladder cancers are sensitive to combination therapies with the EZH2 inhibitor and inhibitors of PI3K, in a synergistic manner.
These changes, seen in a mouse model, are a likely proteome signature for reductive stress cardiomyopathy. About one in six heart failure patients shows reductive stress, according to a 2018 clinical study.
Page 1 of 9